Skip to main content
Log in

Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie

Critical illness polyneuropathy and critical illness myopathy

  • CME Zertifizierte Fortbildung
  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

Zusammenfassung

„Critical illness polyneuropathy“ (CIP) und „critical illness myopathy“ (CIM) sind häufige Komplikationen einer schweren Erkrankung, insbesondere Sepsis, SIRS (systemisches inflammatorisches Response-Syndrom) und Multiorganversagen. Hauptsymptome sind die muskuläre Schwäche und Probleme bei der Entwöhnung von der Beatmung. CIP und CIM führen zu verlängerten Beatmungszeiten, längeren Aufenthalten in Klinik- und Rehabilitationseinrichtungen und zu einer erhöhten Mortalität. Elektrophysiologische Messungen können beide Entitäten relativ früh im Verlauf der Erkrankung nachweisen. Eine frühe leitliniengerechte Sepsistherapie ist das wichtigste Instrument, die Entwicklung einer CIP oder CIM zu vermeiden. Obwohl zurzeit keine spezifische Therapie für CIP und CIM bekannt ist, verbessert die Diagnose das therapeutische Management (Entwöhnung von der Beatmung, frühe Physiotherapie, etc.). Der Beitrag gibt eine Übersicht über die klinischen und diagnostischen Zeichen von CIP und CIM und umreißt aktuelle pathophysiologische und therapeutische Konzepte.

Abstract

Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are frequent complications in critically ill patients and both are associated with sepsis, systemic inflammatory response syndrome (SIRS) and multiorgan failure. Major signs are muscle weakness and problems of weaning from the ventilator. Both CIP and CIM lead to elongated times of ventilation, elongated hospital stay, elongated times of rehabilitation and increased mortality. Electrophysiological measurements help to detect CIP and CIM early in the course of the disease. State of the art sepsis therapy is the major target to prevent the development of CIP and CIM. Although no specific therapy of CIP and CIM has been established in the past, the diagnosis generally improves the therapeutic management (weaning from the ventilator, early physiotherapy, etc.). This review provides an overview of clinical and diagnostic features of CIP and CIM and summarizes current pathophysiological and therapeutic concepts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Axer H, Romeike B, Brunkhorst F et al (2011) Neurological sequelae of sepsis: II) neuromuscular weakness. Open Crit Care Med J 4:8–14

    Article  Google Scholar 

  2. Bierbrauer J, Koch S, Olbricht C et al (2012) Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med 40:647–650

    Article  PubMed  Google Scholar 

  3. Bolton CF, Gilbert JJ, Hahn AF et al (1984) Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 47:1223–1231

    Article  PubMed  CAS  Google Scholar 

  4. Finfer S, Chittock DR, Su SY-S et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297

    Article  PubMed  Google Scholar 

  5. Fletcher SN, Kennedy DD, Ghosh IR et al (2003) Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31:1012–1016

    Article  PubMed  Google Scholar 

  6. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL et al (2005) Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 33:349–354

    Article  PubMed  Google Scholar 

  7. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL et al (2001) Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27:1288–1296

    Article  PubMed  CAS  Google Scholar 

  8. Griffiths RD, Hall JB (2010) Intensive care unit-acquired weakness. Crit Care Med 38:779–787

    Article  PubMed  Google Scholar 

  9. Guarneri B, Bertolini G, Latronico N (2008) Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 79:838–841

    Article  PubMed  CAS  Google Scholar 

  10. Hermans G, De Jonghe B, Bruyninckx F et al (2008) Clinical review: Critical illness polyneuropathy and myopathy. Crit Care 12:238

    Article  PubMed  Google Scholar 

  11. Hermans G, Vanhorebeek I, Derde S et al (2009) Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med 37:S391–397

    Article  PubMed  Google Scholar 

  12. Khan J, Harrison TB, Rich MM et al (2006) Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67:1421–1425

    Article  PubMed  Google Scholar 

  13. Lacomis D, Giuliani MJ, Van Cott A et al (1996) Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 40:645–654

    Article  PubMed  CAS  Google Scholar 

  14. Lacomis D, Zochodne DW, Bird SJ (2000) Critical illness myopathy. Muscle Nerve 23:1785–1788

    Article  PubMed  CAS  Google Scholar 

  15. Lacomis D (2011) Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis 12:197–218

    Article  PubMed  Google Scholar 

  16. Latronico N, Bolton CF (2011) Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 10:931–941

    Article  PubMed  Google Scholar 

  17. Latronico N, Shehu I, Guarneri B (2009) Use of electrophysiologic testing. Crit Care Med 37:S316–320

    Article  PubMed  Google Scholar 

  18. Lefaucheur J-P, Nordine T, Rodriguez P, Brochard L (2006) Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77:500–506

    Article  PubMed  Google Scholar 

  19. Novak KR, Nardelli P, Cope TC et al (2009) Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 119:1150–1158

    Article  PubMed  CAS  Google Scholar 

  20. Rochester CL (2009) Rehabilitation in the intensive care unit. Semin Respir Crit Care Med 30:656–669

    Article  PubMed  Google Scholar 

  21. Schaaf M van der, Beelen A, Vos R de (2004) Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil 26:1189–1197

    Article  PubMed  Google Scholar 

  22. Rich MM, Bird SJ, Raps EC et al (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20:665–673

    Article  PubMed  CAS  Google Scholar 

  23. Stevens RD, Dowdy DW, Michaels RK et al (2007) Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 33:1876–1891

    Article  PubMed  Google Scholar 

  24. Tennila A, Salmi T, Pettila V et al (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26:1360–1363

    Article  PubMed  CAS  Google Scholar 

  25. Trojaborg W (2006) Electrophysiologic techniques in critical illness-associated weakness. J Neurol Sci 242:83–85

    Article  PubMed  Google Scholar 

  26. Weber-Carstens S, Deja M, Koch S et al (2010) Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 14:R119

    Article  PubMed  Google Scholar 

  27. Weber-Carstens S, Koch S, Spuler S et al (2009) Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 37:2632–2637

    Article  PubMed  Google Scholar 

  28. Wehler M (2011) Langzeitprognose alter Patienten nach intensiv-medizinischer Behandlung. Med Klin Intensivmed Notfmed 106:29–33

    Article  PubMed  CAS  Google Scholar 

  29. Wieske L, Harmsen RE, Schultz MJ et al (2011) Is critical illness neuromyopathy and duration of mechanical ventilation decreased by strict glucose control? Neurocrit Care 14:475–481

    Article  PubMed  Google Scholar 

  30. Witt NJ, Zochodne DW, Bolton CF et al (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176–184

    Article  PubMed  CAS  Google Scholar 

  31. Zink W, Kollmar R, Schwab S (2009) Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol 5:372–379

    Article  PubMed  Google Scholar 

Download references

Danksagung

Diese Arbeit wurden durch das Bundesministerium für Bildung und Forschung (BMBF), FKZ: 01EO1002, gefördert.

Interessenkonflikte

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Axer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grimm, A., Günther, A., Witte, O. et al. Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie . Med Klin Intensivmed Notfmed 107, 649–660 (2012). https://doi.org/10.1007/s00063-012-0186-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-012-0186-y

Schlüsselwörter

Keywords

Navigation